SAN CARLOS, Calif. & SAN FRANCISCO–NuGEN Technologies Inc. and Ion Torrent, a unit of Life Technologies Corporation (NASDAQ:LIFE), today announced the release of three new products developed by NuGEN for the Ion Personal Genome Machine™ (PGM™). Ion PGM customers can now order the NuGEN Encore® NGS Library Systems for Ion Torrent from the Ion Torrent webstore; these products are also available for purchase directly from NuGEN.

The Encore NGS Library Systems for Ion Torrent afford rapid and efficient library construction to produce DNA libraries from as little as 100ng of DNA in a streamlined workflow that does not require specialized equipment to perform size selection. Sequencing libraries can be created for a wide range of applications and kit selection offers the option of 16-Plex multiplex sequencing on an Ion chip.

“NuGEN is pleased to provide enabling solutions for scientists using the Ion PGM sequencer,” said Elizabeth Hutt, CEO of NuGEN Technologies. “This expansion of our Encore Library family further demonstrates the utility of our technology across a broad range of genomic platforms and applications. Our commitment to provide innovative solutions for simplifying workflows and optimizing cost and efficiency through multiplexing will accelerate important scientific discoveries.”

“As part of our developers’ network, NuGEN has rapidly developed these Encore kits for the Ion PGM sequencing system to expand the scope of applications for our customers,” said Gregg Fergus, Ion Torrent’s President and COO. “We are pleased to make these novel products available directly and through our webstore to enable the fastest growing NGS customer base to purchase all their Ion Torrent and Ion compatible products simply and with confidence.”

About NuGEN

NuGEN provides revolutionary RNA and DNA sample preparation technologies that enable life scientists to do more with less. With innovative reagent solutions that are quick and easy to use, NuGEN empowers researchers to prepare genomic samples of any size, from almost any source, regardless of the intended application or technology platform. For more information please visit www.nugeninc.com.

About Life Technologies (www.lifetechnologies.com) Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies’ industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and TaqMan products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.